Literature DB >> 1468426

Erysipelas-like skin lesions associated with Campylobacter jejuni septicemia in patients with hypogammaglobulinemia.

P J Kerstens1, H P Endtz, J F Meis, W J Oyen, R J Koopman, P J van den Broek, J W van der Meer.   

Abstract

Three cases are reported of hypogammaglobulinemic males with recurrent Campylobacter jejuni septicemia and erysipelas-like cellulitis without diarrhoea. In one patient Campylobacter jejuni grew from skin biopsy specimens. The findings in another patient were strongly suggestive of osteomyelitis caused by Campylobacter jejuni. Since the susceptibility of hypogammaglobulinemic patients to infection with Campylobacter jejuni is probably related to a lack of serum bactericidal activity against Campylobacter jejuni due to lack of IgM, two patients in whom previous antimicrobial treatment failed were treated with plasma infusions. This regimen supplemented with imipenem resulted in cure of these relapsing infections. Campylobacter jejuni septicemia must be considered in hypogammaglobulinemic patients who present with periodic fever and cellulitis.

Entities:  

Mesh:

Year:  1992        PMID: 1468426     DOI: 10.1007/bf01960888

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  23 in total

1.  Fluoroquinolone resistance in Campylobacter spp isolated from human stools and poultry products.

Authors:  H P Endtz; R P Mouton; T van der Reyden; G J Ruijs; M Biever; B van Klingeren
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321

2.  Diagnosis of bone, joint, and joint prosthesis infections with In-111-labeled nonspecific human immunoglobulin G scintigraphy.

Authors:  W J Oyen; J R van Horn; R A Claessens; T J Slooff; J W van der Meer; F H Corstens
Journal:  Radiology       Date:  1992-01       Impact factor: 11.105

3.  Improved toluidine blue-DNA agar for detection of DNA hydrolysis by campylobacters.

Authors:  H Lior; A Patel
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

4.  Campylobacter serotyping a epidemiology.

Authors:  S Lauwers; L Vlaes; J P Butzler
Journal:  Lancet       Date:  1981-01-17       Impact factor: 79.321

5.  Persistent Campylobacter jejuni infections in patients infected with the human immunodeficiency virus (HIV).

Authors:  D M Perlman; N M Ampel; R B Schifman; D L Cohn; C M Patton; M L Aguirre; W L Wang; M J Blaser
Journal:  Ann Intern Med       Date:  1988-04       Impact factor: 25.391

6.  Prolonged campylobacter gastroenteritis in a patient with hypogammaglobulinaemia.

Authors:  A Pönkä; R Tilvis; T U Kosunen
Journal:  Acta Med Scand       Date:  1983

7.  Campylobacter enteritis in immune-deficient patients.

Authors:  D J Ahnen; W R Brown
Journal:  Ann Intern Med       Date:  1982-02       Impact factor: 25.391

8.  Chronic campylobacter colitis and uveitis in patient with hypogammaglobulinaemia.

Authors:  A M Lever; J M Dolby; A D Webster; A B Price
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-18

Review 9.  X-linked agammaglobulinemia: an analysis of 96 patients.

Authors:  H M Lederman; J A Winkelstein
Journal:  Medicine (Baltimore)       Date:  1985-05       Impact factor: 1.889

10.  Campylobacter bacteraemia: a report of 10 cases.

Authors:  D W Spelman; N Davidson; N D Buckmaster; W J Spicer; P Ryan
Journal:  Med J Aust       Date:  1986-11-17       Impact factor: 7.738

View more
  19 in total

Review 1.  Clinical aspects of Campylobacter jejuni infections in adults.

Authors:  M C Peterson
Journal:  West J Med       Date:  1994-08

2.  Campylobacter jejuni cellulitis in a patient with pan-hypogammaglobulinaemia.

Authors:  S Hopkins; M Abuzakouk; E Brannigan; C Bergin; C Feighery
Journal:  BMJ Case Rep       Date:  2011-02-02

Review 3.  A case of cellulitis complicating Campylobacter jejuni subspecies jejuni bacteremia and review of the literature.

Authors:  A Monselise; D Blickstein; I Ostfeld; R Segal; M Weinberger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-08-24       Impact factor: 3.267

4.  Use of an immunoglobulin M containing preparation for treatment of two hypogammaglobulinemic patients with persistent Campylobacter jejuni infection.

Authors:  J C Borleffs; J F Schellekens; E Brouwer; M Rozenberg-Arska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

5.  Recrudescent Campylobacter jejuni infection in an immunocompetent adult following experimental infection with a well-characterized organism.

Authors:  Shahida Baqar; David R Tribble; Marya Carmolli; Katrin Sadigh; Frederic Poly; Chad Porter; Catherine J Larsson; Kristen K Pierce; Patricia Guerry; Michael Darsley; Beth Kirkpatrick
Journal:  Clin Vaccine Immunol       Date:  2009-11-18

6.  Persistence of Campylobacter fetus bacteremia associated with absence of opsonizing antibodies.

Authors:  K M Neuzil; E Wang; D W Haas; M J Blaser
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

7.  Bactericidal properties of Campylobacter jejuni-specific immunoglobulin M antibodies in commercial immunoglobulin preparations.

Authors:  I B Autenrieth; A Schwarzkopf; J H Ewald; H Karch; R Lissner
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

8.  Serum bactericidal activity against Helicobacter pylori in patients with hypogammaglobulinaemia.

Authors:  I M E Desar; M van Deuren; T Sprong; J B M J Jansen; F Namavar; C M Vandenbroucke-Grauls; J W M van der Meer
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

9.  Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.

Authors:  Mirva Lehtopolku; Ulla-Maija Nakari; Pirkko Kotilainen; Pentti Huovinen; Anja Siitonen; Antti J Hakanen
Journal:  Antimicrob Agents Chemother       Date:  2009-12-28       Impact factor: 5.191

Review 10.  X-linked hypogammaglobulinemia and isolated growth hormone deficiency: an update.

Authors:  Donn M Stewart; Lan Tian; Luigi D Notarangelo; David L Nelson
Journal:  Immunol Res       Date:  2008       Impact factor: 4.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.